(a) Specifications.
The drug is a sol- uble powder containing bicyclohexylammonium fumagillin and appropriate phosphate buffers.
(b) Sponsor.
See No. 059620 in § 510.600(c) of this chapter.
(c) Conditions of use.
(1)
The drug is used for the prevention of nosema in honey bees. 1
Code of Federal Regulations
Footnote(s):
1 These conditions are NAS/NRC reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by § 514.111 of this chapter, but may require bioequivalency and safety information.
(2)
It is administered usually in a 2:1 sugar sirup containing a concentration of from 75 to 100 milligrams of fumagillin activity per gallon of sugar sirup. 1
(3)
Colonies used for package production should be fed medicated sirup as a principal food supply for a month prior to stocking nuclei or shaking packages for market. 1
(4)
The medicated sirup should not be fed immediately before or during the honey flow.
Code of Federal Regulations
[40 FR 13838, Mar. 27, 1975, as amended at 42 FR 65151, Dec. 30, 1977; 56 FR 43699, Sept. 4, 1991; 58 FR 5608, Jan. 22, 1993]